Skip to main content
. 2020 May 15;10(14):6201–6215. doi: 10.7150/thno.46137

Figure 8.

Figure 8

Procaterol inhibits gastric tumor growth in PDXs. A. Patient information of different PDX cases. Gender, age, pathological grade, clinical phases, smoking history, alcohol history and basic diseases are shown. B. Effects procaterol (75 μg/kg/day) administered by gavage. Tumor volumes of four different cases of PDX models were recorded. Tumors in each case are shown. Data represent means ±SD. P<0.05: *, p<0.01: **, p<0.001: ***. Significance determined by two-tailed Student's t test.